Comparing treatment efficacy of Melasma by two different wavelengths of Q Switched Nd YAG laser

A split face study of laser toning versus 1064/532nm using Q switched Neodymium Doped Yittrium Argon Garnet Laser in Melasma

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024300

Enrollment

Registered

2020-03-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: A split face study of laser toning versus 1064/532nm using Q switched Neodymium Doped Yittrium Argon Garnet Laser in Melasma: comparision of effect of 1064nm wavelength of Q switched Ne

Eligibility

Inclusion criteria

Inclusion criteria: not on any treatment for melasma for last 01 month

Exclusion criteria

Exclusion criteria: pregnant females, use of other treatment modalities within last 01 month, photosensitive dermatoses, reaction after test patch

Design outcomes

Primary

Measure	Time frame
reduction in Hemi MASI scoreTimepoint: reduction in Hemi MASI score at 4, 8, 12 and 16 weeks from start of laser sessions	—

Secondary

Measure	Time frame
lightening of pigmentation in MelasmaTimepoint: 4, 8, 12 & 16 weeks	—

Countries

India

Contacts

Public ContactReetika Pal

Command Hospital Air Force, Bangalore

aroraderma@gmail.com9910411635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026